本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

467.16
-4.5900-0.97%
盘后:467.160.00000.00%19:30 EDT
成交量:46.93万
成交额:2.19亿
市值:107.71亿
市盈率:-32.86
高:478.85
开:471.75
低:460.22
收:471.75
52周最高:615.00
52周最低:393.61
股本:2,305.55万
流通股本:1,372.50万
量比:1.54
换手率:3.42%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
净资产收益率:-53.31%
总资产收益率:-17.84%
市净率:20.57
市盈率(LYR):-36.35

数据加载中...

2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities